Cancer patients receiving drugs to lower the risk of anaemia...
Published Tuesday 01 December 2009
Chemotherapy can result in insomnia
Insomnia occurs in approximately three-quarters of cancer patients who have...
Published Tuesday 01 December 2009
Osteoarthritis risk increased by high exercise levels
Men and women in middle age who exercise on a...
Published Monday 30 November 2009
Cancer genome changes increase cervical cancer relapse risk
Patients with cervical cancer are three to four times more...
Published Sunday 29 November 2009
More Medical News
Meningitis
Please note- The EPG Meningitis Knowledge Centre is for Doctors and other Healthcare Professionals.
Meningitis is usually caused by bacteria or viruses but may also be caused by fungi and amoebae. The severity of the disease is dependent on the causal agent.
The main causes of meningitis include:
- Bacterial meningitis: Many different bacteria may cause meningitis but those with the highest incidence are Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae.
- Neonatal meningitis: Some forms of meningitis predominantly affect neonates, as newborn babies have immature immune systems and so are particularly susceptible to infection.
- Viral: Viral or ‘aseptic’ meningitis is the most common type of meningitis. It can be very debilitating but is generally far less severe than bacterial meningitis and is rarely fatal.
- Other: Viruses and bacteria are the most common causes of meningitis; however other organisms, such as fungi and amoeba, may also cause this disease, although these cases are extremely rare.
There are several risk factors associated with meningitis and the majority of organisms that cause meningitis are transmitted from person to person via droplets of respiratory or throat secretions.
Meningitis and septicaemia are often difficult to recognise at first as the early symptoms and signs of these two diseases can be mistaken for other, more common diseases. Both are life-threatening conditions which require urgent medical attention and immediate treatment with antibiotics.
Vaccination is the most effective method of preventing meningitis. However, there is no single vaccine that protects against all forms of the disease.
Enter the Meningitis Knowledge Centre
What’s in the Meningitis Knowledge Centre?
- Home
- Types/Causes
- Bacterial meningitis
- Neonatal meningitis
- Viral meningitis
- Other causes of meningitis
- Transmission
- Incidence
- Meningococcal Meningitis
- Pneumococcal Meningitis
- Hib Meningitis
- Risk Factors
- Symptoms
- Impact
- Identification
- Diagnosing
- Diagnosis of Bacterial Meningitis
- Neuro-imaging Studies
- Diagnosis of Viral Meningitis
- Clinical Features
- Treatment Antibiotic Treatment
- Anti-inflammatory Agents
- Reduction of Intracranial Pressure
- Surgery
- Chemoprophylaxis
- Anti-viral Therapy
- Non-pharmacological
- Referral
- Monitoring
- Vaccination
- Bacterial meningitis
- N. Meningitis
- S. Pneumoniae
- Viral
- Current vaccination policies in European countries
- Chemoprophylaxis
- Risk Reduction
- Web Links
- FAQ's
- AIDS
- Amoeba
- Antibiotic
- Antigen
- Bacterium
- Basilar skull fracture
- Capsular polysaccharide
- Carrier
- Cerebrospinal fluid (CSF)
- Chemoprophylaxis
- Conjugate vaccine
- Encephalitis
- Endemic
- Epidemic
- Epidemiology
- Fontanelle
- Fungus
- Gram stain
- Haemorrhagic rash
- Hib disease
- Hib meningitis
- Hib vaccine
- Hypoglycorrhachia
- Immunocompromised
- Immunodeficient
- Immunogenicity
- Immunosuppressed
- Meningitis C (MenC) vaccine
- Meningitis C conjugate (MenCC) vaccine
- Meninges
- Meningitis
- Meningitis belt
- Meningococcal disease
- Meningococcal meningitis
- Meningococcus
- Nasopharynx
- Neisseria meningitidis
- Neonate
- Pleocytosis
- Pneumococcal conjugate vaccine (PCV)
- Pneumococcal disease
- Pneumococcal meningitis
- Pneumococcus
- Polysaccharide vaccine
- Septicaemia
- Sequela
- Serogroup
- Sterile
- Subarachnoid space
- Tinnitus
- Virus
-
KEFADIM - 47.03%
... Gynaecological infections Intra-abdominal infections, including peritonitis Septicaemia Central nervous system infections, including meningitis. In meningitis, it is recommended that the results of a sensitivity test are known before treatment with ceftazidime as a single agent. Kefadim may be used ... -
FLOXAPEN Syrup - 46.1%
... and externa, Tonsillitis, Quinsy Other infections caused by Floxapen-sensitive organisms: Osteomyelitis, Urinary tract infection, Enteritis, Meningitis, Endocarditis, Septicaemia Floxapen is also indicated for use as a prophylactic agent during major surgical procedures when appropriate; for example ... -
PREVENAR SUSPENSION FOR INJECTION - 46.1%
Active immunisation against invasive disease (including sepsis, meningitis, bacteraemic pneumonia, bacteraemia) caused by Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F and 23F in: - infants and young children from 2 months of age to 2 years of age - previously unvaccinated children aged ... -
MENGIVAC (A+C) - 46.1%
Active immunisation against Types A and C meningitis ... -
AC VAX - 46.1%
Active immunisation against Types A and C meningitis ... -
MENINGITEC - 46.1%
Active immunisation of children from 2 months of age, adolescents and adults for the prevention of invasive disease caused by Neisseria meningitis serogroup C. The use of Meningitec should be determined on the basis of official recommendations ...

Medical News